Gene · 6523
Papers3,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Parallel Erosion of a Testis-Specific Na+/K+ ATPase in Three Mammalian Lineages Sheds Light into the Evolution of Spermatozoa Energetics. | Genome Biol Evol | 2026 | 41626717 | PubTator, text mining | PubMed |
| Pharmacokinetic changes and mechanisms of salidroside in hypobaric hypoxic environment: A LC-MS and proteomics study. | J Ethnopharmacol | 2026 | 41548618 | PubTator, text mining | PubMed |
| Porcine serum maltase-glucoamylase: structure, kinetics, and inhibition. | J Enzyme Inhib Med Chem | 2026 | 41534875 | PubTator, text mining | PubMed |
| Sodium-Glucose Cotransporter 2 Inhibitors as Emerging Anticancer Agents. | Diabetes Metab J | 2026 | 41531286 | PubTator, text mining | PubMed |
| In-vitro and in-silico evaluations of bioactive compounds, radical scavenging properties, antidiabetic and antiinflammatory properties of extract and fractions of Combretum racemosum leaf. | In Silico Pharmacol | 2026 | 41522706 | PubTator, text mining | PubMed |
| Central control of gastrointestinal functions in health and disease. | Physiol Rev | 2026 | 41432726 | PubTator, text mining | PubMed |
Upcycled Green Coffee Phenolic-Rich Extract Modulates Key Pathways of Glucose Absorption in Caco-2 Cells: Findings From a Screening of Upcycled Agro-Industrial By-Products for Application in Functional Foods. | Mol Nutr Food Res | 2026 | 41362078 | PubTator, text mining | PubMed |
| Development of glycoside-based nuclear medicine imaging agents for the sodium-glucose co-transporters in cancer cells. | Nucl Med Biol | 2026 | 41352328 | PubTator, text mining | PubMed |
The Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass: a Proof-of-Concept, Randomized, Open-Label, Crossover Study. | Obes Surg | 2026 | 41313432 | PubTator, text mining | PubMed |
| Impact of Dapagliflozin on insulin signaling and neuronal survival in stretch-induced traumatic brain injury model. | Biochem Pharmacol | 2026 | 41110488 | PubTator, text mining | PubMed |
| Sotagliflozin: Two Birds with One Stone? | Cardiovasc Drugs Ther | 2026 | 40465110 | PubTator, text mining | PubMed |
| Global Trends in Research of Intestinal Cells and Type 2 Diabetes Mellitus: A Bibliometric and Visualized Analysis from 2004 to 2023. | Endocr Metab Immune Disord Drug Targets | 2026 | 40192044 | PubTator, text mining | PubMed |
| A Review of Sotagliflozin: The First Dual SGLT-1/2 Inhibitor. | Cardiol Rev | 2026 | 39072631 | PubTator, text mining | PubMed |
In Silico Transcriptomic Analysis for Identification of Potential Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer using a Hybrid Genetic Algorithm-Support Vector Machine Approach. | Arch Iran Med | 2025 | 41852002 | PubTator, text mining | PubMed |
In vitro evaluation of bio-fortification effects on the nutritional quality, toxicological safety, and antioxidant of cassava (Manihot esculenta) flour, and environmental safety of processing water, using natural additives. | Front Nutr | 2025 | 41710592 | PubTator, text mining | PubMed |
| Curcumin and bisdemethoxycurcumin inhibit glucose and enhance fructose absorption in differentiated Caco-2 cells, while dibenzoylmethane inhibits glucose absorption. | Food Res Int | 2025 | 41606929 | PubTator, text mining | PubMed |
| Next-Generation SGLT2 Inhibitors: Innovations and Clinical Perspectives. | Biomedicines | 2025 | 41595617 | PubTator, text mining | PubMed |
| Molecular subtyping and functional characterization of gastric cancer using arginine metabolism-related genes. | Front Cell Dev Biol | 2025 | 41573681 | PubTator, text mining | PubMed |
| A low-calorie rebaudioside D-glucose-sodium sweetener matches sucrose in palatability and neural responses in a functional MRI study of healthy adults. | Front Nutr | 2025 | 41572976 | PubTator, text mining | PubMed |
| Dual SGLT1/2 inhibition with sotagliflozin: a pharmaceutical breakthrough in heart failure management and cardiometabolic risk reduction. | Front Med (Lausanne) | 2025 | 41551500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6523/papers?page=4